The lysophosphatidylserine receptor GPR174 constrains regulatory T cell development and function
Barnes et al. show that a bioactive lipid, lysophosphatidylserine, negatively influences T reg cell accumulation and activity through one of its receptors, GPR174. The authors speculate that GPR174 antagonism may be therapeutic for autoimmune diseases.
Main Authors: | Barnes, Michael J., Li, Chien-Ming, Xu, Ying, An, Jinping, Huang, Yong, Cyster, Jason G. |
---|---|
Format: | Online |
Language: | English |
Published: |
The Rockefeller University Press
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4493414/ |
Similar Items
-
Blood levels of serotonin are specifically correlated with plasma lysophosphatidylserine among the glycero-lysophospholipids
by: Kurano, Makoto, et al.
Published: (2015) -
Immunomodulatory lysophosphatidylserines are regulated by ABHD16A and ABHD12 interplay
by: Kamat, Siddhesh S., et al.
Published: (2015) -
An X chromosome-wide association analysis identifies variants in GPR174 as a risk factor for Graves’ disease
by: Chu, Xun, et al.
Published: (2013) -
GPR18 is required for a normal CD8αα intestinal intraepithelial lymphocyte compartment
by: Wang, Xiaoming, et al.
Published: (2014) -
Gpr116 Receptor Regulates Distinctive Functions in Pneumocytes and Vascular Endothelium
by: Niaudet, Colin, et al.
Published: (2015)